Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
SLN:NASDAQ
Silence Therapeutics PLC - ADR
$7.84
-1.63%
(-0.13) 1D
$7.69
-1.91% (-0.15)
After hours
Closed: Apr 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLN...
Open
$7.90
High
$8.40
Low
$7.78
Mkt. cap
370.31M
Avg. vol.
400.45K
Volume
0.00
52-wk high
$8.40
52-wk low
$3.08
EPS
-$1.88
Beta
1.34
Shares outstanding
47.23M
No. of employees
88
News stories
From sources across the web
Profile
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
About Silence Therapeutics PLC - ADR
CEOCraig A Tooman
Employees88
Founded1994
Headquarters-
SectorBiotechnology
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
142.00K
224.00K
159.00K
34.00K
Cost of goods sold
54.00K
85.00K
64.00K
12.00K
Cost of revenue
54.00K
85.00K
64.00K
12.00K
Research and development expenses
18.13M
15.28M
17.96M
8.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.68M
5.13M
5.80M
3.73M
Operating expense
25.82M
20.41M
23.76M
12.65M
Total operating expenses
25.87M
20.49M
23.82M
12.66M
Operating income
-25.73M
-20.27M
-23.66M
-12.63M
Other non operating income
969.00K
861.00K
770.00K
865.00K
EBT including unusual items
-28.53M
-27.34M
-20.96M
-11.77M
EBT excluding unusual items
-28.53M
-26.02M
-20.96M
-11.77M
Income tax expense
-
10.00K
1.00K
-
Effective tax rate
-
-0.04%
-
-
Other operating expenses
-
-
-
-
Net income
-28.53M
-27.35M
-20.96M
-11.77M
Net profit margin
-20,091.55%
-12,211.61%
-13,181.13%
-34,617.65%
Earnings per share
-0.60
-0.55
-0.15
-0.27
Interest and investment income
-
-
-
15.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
-
15.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.59M
-20.12M
-23.50M
-12.52M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more